3 Day Masterclass in Orphan Drugs | Terrapinn Training

New York, 30 Oct - 1 Nov 2017


3 day Masterclass

Orphan Drugs

WRITE AN ORPHAN DRUG DESIGNATION ARGUE A LEGAL CASE WRITE A BUSINESS PLAN

SEIZE OPPORTUNITIES IN THE ORPHAN DRUG MARKET.

The 3 day masterclass in Orphan Drugs is for professionals who want to learn more about the details of entering the orphan drug market and the business of rare diseases. This course will help you identify business opportunities and new trends in medical therapy for patients with rare diseases.

Learn bulb

develop new skills

Learn to write an orphan drug designation for FDA and EMA

Learn bulb

fully engage

Argue a court case on the legal aspects of the Orphan Drug Act

Learn bulb

get practical

Write a business plan for developing a business based on new therapies for rare diseases

ENHANCE YOUR KNOWLEDGE THROUGH PRACTICAL LEARNING

This interactive course has been designed to teach participants through practical exercises that pertain to three key aspects of the orphan drug market: how to write an orphan drug designation, how to argue a legal case and how to write a business plan based on a rare disease therapy. 

 

book today saving USD $780

In just 3 days you will:

  • Learn how to write an orphan drug designation for the Food and Drug Administration or European Medicines Agency
  • Understand how to argue a legal case on the Orphan Drug Act
  • Write a business plan for an orphan drug involving advanced new therapies
  • Discover many facts, issues and examples of rare disease market

Meet your instructor

Ian Philips teaching Orphan Drugs for Terrapinn Training

Ian Philips, PhD, DSc is a professor of Life Science and Director of a major center for Rare Disease Therapies. He was trained in neuropharmacology at the universities of Exeter and Birmingham in the UK, Heidelberg in Germany and Zurich in Switzerland. He has held academic positions at the California Institute of Technology, Universities of Iowa, Florida and South Florida

Organisations that will benefit:

  • Pharmaceutical & Biotech Companies
  • Rare Disease Research Organisations
  • Suppliers
  • Investors

Who will attend:

  • C-Level Executives: CEO, CFO, COO
  • Business Development and Sales
  • Researchers

Course Agenda

  • Big Picture
  • Speed Networking
  • Objectives and Orphan Drug Overview
  • Drug Development
  • Orphan Drug Designation
  • Workshop 1: Write an orphan drug designation
  • Why rare diseases?
  • Regulatory Affairs
  • Orphan drugs access
  • Workshop 2: Participants argue a legal case
  • Precision medicine
  • Business Plans
  • Workshop 3: Write a business plan based on a rare disease therapy
  • Review of business plans
  • Wrap Up

For further information please call: +44 (0)207 092 1045

The earlier you book, the more you save…

Additionally, VAT may be applicable depending on course location.
Before 11 Aug 2017Before 22 Sep 2017Before 13 Oct 2017After 13 Oct 2017
USD $3,510
Save USD $780
USD $3,900
Save USD $390
USD $4,095
Save USD $195
USD $4,290
  • “The depth and knowledge of my trainer was extremely impressive. In 3 days I have had, without a doubt, a masterclass on the industry. Truly world class.”

    - Gordon Dowall Potter, Past Delegate

  • “Well worth 3 days of study!”

    - Syed Hamza, Past Delegate

  • “The training was excellent! I give it a 10 and will get my trainer's support for my next challenges.”

    - Head of Partnerships & Customer Loyalty at Avis Budget, Past Delegate

  • “Extremely constructive course with a very good dynamic and passionate trainer.”

    - Managing Director at BNP Paribas, Past Delegate

  • “Impressive and cooperative trainer who wanted to make sure the delegates understood.”

    - Budgeting, Planning & Reporting Manager, Past Delegate

IN-HOUSE

We can come to you too! If you have a team of six or more, why not hold a private course? Our experts come to you and the course is tailored to your requirements.

Call +44 (0)20 7092 1045 (United Kingdom)
or +65 6322 2333 (Asia Pacific)
for more details

FIND OUT MORE